{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34711813",
  "DateCompleted": {
    "Year": "2021",
    "Month": "11",
    "Day": "12"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "11",
    "Day": "08"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "10",
        "Day": "28"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "6220",
      "10.1038/s41467-021-26459-6"
    ],
    "Journal": {
      "ISSN": "2041-1723",
      "JournalIssue": {
        "Volume": "12",
        "Issue": "1",
        "PubDate": {
          "Year": "2021",
          "Month": "Oct",
          "Day": "28"
        }
      },
      "Title": "Nature communications",
      "ISOAbbreviation": "Nat Commun"
    },
    "ArticleTitle": "Effectiveness of ChAdOx1 vaccine in older adults during SARS-CoV-2 Gamma variant circulation in S\u00e3o Paulo.",
    "Pagination": {
      "StartPage": "6220",
      "MedlinePgn": "6220"
    },
    "Abstract": {
      "AbstractText": [
        "A two-dose regimen of the Oxford-AstraZeneca (ChAdOx1) Covid-19 vaccine with an inter-dose interval of three months has been implemented in many countries with restricted vaccine supply. However, there is limited evidence for the effectiveness of ChAdOx1 by dose in elderly populations in countries with high prevalence of the Gamma variant of SARS-CoV-2. Here, we estimate ChAdOx1 effectiveness by dose against the primary endpoint of RT-PCR-confirmed Covid-19, and secondary endpoints of Covid-19 hospitalization and Covid-19-related death, in adults aged \u226560 years during an epidemic with high Gamma variant prevalence in S\u00e3o Paulo state, Brazil using a matched, test-negative case-control study. Starting 28 days after the first dose, effectiveness of a single dose of ChAdOx1 is 33.4% (95% CI, 26.4-39.7) against Covid-19, 55.1% (95% CI, 46.6-62.2) against hospitalization, and 61.8% (95% CI, 48.9-71.4) against death. Starting 14 days after the second dose, effectiveness of the two-dose schedule is 77.9% (95% CI, 69.2-84.2) against Covid-19, 87.6% (95% CI, 78.2-92.9) against hospitalization, and 93.6% (95% CI, 81.9-97.7) against death. Completion of the ChAdOx1 vaccine schedule affords significantly increased protection over a single dose against mild and severe Covid-19 outcomes in elderly individuals during widespread Gamma variant circulation."
      ],
      "CopyrightInformation": "\u00a9 2021. The Author(s)."
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0003-2327-3557"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Biostatistics, College of Public Health & Health Professions, University of Florida, Gainesville, FL, USA."
          }
        ],
        "LastName": "Hitchings",
        "ForeName": "Matt D T",
        "Initials": "MDT"
      },
      {
        "Identifier": [
          "0000-0002-4677-6862"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Barcelona Institute for Global Health, ISGlobal, Barcelona, Spain."
          },
          {
            "Identifier": [],
            "Affiliation": "Pulmonary Division, Heart Institute (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de S\u00e3o Paulo, S\u00e3o Paulo, S\u00e3o Paulo, Brazil."
          }
        ],
        "LastName": "Ranzani",
        "ForeName": "Otavio T",
        "Initials": "OT"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA."
          }
        ],
        "LastName": "Dorion",
        "ForeName": "Murilo",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Disease Control Coordination of the S\u00e3o Paulo State Department of Health, S\u00e3o Paulo, S\u00e3o Paulo, Brazil."
          }
        ],
        "LastName": "D'Agostini",
        "ForeName": "Tatiana Lang",
        "Initials": "TL"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Disease Control Coordination of the S\u00e3o Paulo State Department of Health, S\u00e3o Paulo, S\u00e3o Paulo, Brazil."
          }
        ],
        "LastName": "de Paula",
        "ForeName": "Regiane Cardoso",
        "Initials": "RC"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Disease Control Coordination of the S\u00e3o Paulo State Department of Health, S\u00e3o Paulo, S\u00e3o Paulo, Brazil."
          }
        ],
        "LastName": "de Paula",
        "ForeName": "Olivia Ferreira Pereira",
        "Initials": "OFP"
      },
      {
        "Identifier": [
          "0000-0002-7043-2007"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Disease Control Coordination of the S\u00e3o Paulo State Department of Health, S\u00e3o Paulo, S\u00e3o Paulo, Brazil."
          }
        ],
        "LastName": "de Moura Villela",
        "ForeName": "Edlaine Faria",
        "Initials": "EF"
      },
      {
        "Identifier": [
          "0000-0002-2050-7648"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Municipal Health Secretary of Manaus, Manaus, Amazonas, Brazil."
          }
        ],
        "LastName": "Torres",
        "ForeName": "Mario Sergio Scaramuzzini",
        "Initials": "MSS"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Pan American Health Organization, Bras\u00edlia, Distrito Federal, Brazil."
          },
          {
            "Identifier": [],
            "Affiliation": "Universidade de Bras\u00edlia, Bras\u00edlia, Distrito Federal, Brazil."
          }
        ],
        "LastName": "de Oliveira",
        "ForeName": "Silvano Barbosa",
        "Initials": "SB"
      },
      {
        "Identifier": [
          "0000-0002-2048-4028"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT, USA."
          }
        ],
        "LastName": "Schulz",
        "ForeName": "Wade",
        "Initials": "W"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Pan American Health Organization, Bras\u00edlia, Distrito Federal, Brazil."
          }
        ],
        "LastName": "Almiron",
        "ForeName": "Maria",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Pan American Health Organization, Bras\u00edlia, Distrito Federal, Brazil."
          }
        ],
        "LastName": "Said",
        "ForeName": "Rodrigo",
        "Initials": "R"
      },
      {
        "Identifier": [
          "0000-0001-7996-8011"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "State University of Mato Grosso do Sul - UEMS, Dourados, Mato Grosso do Sul, Brazil."
          }
        ],
        "LastName": "de Oliveira",
        "ForeName": "Roberto Dias",
        "Initials": "RD"
      },
      {
        "Identifier": [
          "0000-0001-6632-7848"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Universidade Federal de Mato Grosso do Sul - UFMS, Campo Grande, Mato Grosso do Sul, Brazil."
          }
        ],
        "LastName": "Silva",
        "ForeName": "Patricia Vieira",
        "Initials": "PV"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Pan American Health Organization, Bras\u00edlia, Distrito Federal, Brazil."
          },
          {
            "Identifier": [],
            "Affiliation": "Universidade de Bras\u00edlia, Bras\u00edlia, Distrito Federal, Brazil."
          },
          {
            "Identifier": [],
            "Affiliation": "National Institute for Science and Technology for Health Technology Assessment, Porto Alegre, Rio Grande do Sul, Brazil."
          }
        ],
        "LastName": "de Ara\u00fajo",
        "ForeName": "Wildo Navegantes",
        "Initials": "WN"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Health Secretariat of the State of S\u00e3o Paulo, S\u00e3o Paulo, S\u00e3o Paulo, Brazil."
          }
        ],
        "LastName": "Gorinchteyn",
        "ForeName": "Jean Carlo",
        "Initials": "JC"
      },
      {
        "Identifier": [
          "0000-0002-5967-251X"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA, USA."
          }
        ],
        "LastName": "Andrews",
        "ForeName": "Jason R",
        "Initials": "JR"
      },
      {
        "Identifier": [
          "0000-0002-9437-1907"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Biology, University of Florida, Gainesville, FL, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA."
          }
        ],
        "LastName": "Cummings",
        "ForeName": "Derek A T",
        "Initials": "DAT"
      },
      {
        "Identifier": [
          "0000-0001-9023-2339"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Instituto Gon\u00e7alo Moniz, Funda\u00e7\u00e3o Oswaldo Cruz, Salvador, Bahia, Brazil."
          }
        ],
        "LastName": "Ko",
        "ForeName": "Albert I",
        "Initials": "AI"
      },
      {
        "Identifier": [
          "0000-0002-6665-6825"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA. julio.croda@fiocruz.br."
          },
          {
            "Identifier": [],
            "Affiliation": "Universidade Federal de Mato Grosso do Sul - UFMS, Campo Grande, Mato Grosso do Sul, Brazil. julio.croda@fiocruz.br."
          },
          {
            "Identifier": [],
            "Affiliation": "Fiocruz Mato Grosso do Sul, Funda\u00e7\u00e3o Oswaldo Cruz, Campo Grande, Mato Grosso do Sul, Brazil. julio.croda@fiocruz.br."
          }
        ],
        "LastName": "Croda",
        "ForeName": "Julio",
        "Initials": "J"
      }
    ],
    "GrantList": [
      {
        "GrantID": "UL1 TR001863",
        "Acronym": "TR",
        "Agency": "NCATS NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Nat Commun",
    "NlmUniqueID": "101528555",
    "ISSNLinking": "2041-1723"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "COVID-19 Vaccines"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Brazil"
    },
    {
      "QualifierName": [
        "epidemiology",
        "immunology",
        "prevention & control"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "immunology",
        "therapeutic use"
      ],
      "DescriptorName": "COVID-19 Vaccines"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Case-Control Studies"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [
        "immunology",
        "metabolism",
        "pathogenicity"
      ],
      "DescriptorName": "SARS-CoV-2"
    }
  ],
  "CoiStatement": "All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no support from any organization for the submitted work; no financial relationships with any organizations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work. All funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The Health Secretary of State of S\u00e3o Paulo and PRODESP reviewed the data and findings of the study, but the academic authors retained editorial control. O.T.R., M.D.T.H., M.S.S.T., O.F.F.P., and J.C. had full access to de-identified data in the study and OTR and M.D.T.H. verified the data, and all authors approved the final version of the manuscript for publication."
}